Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome : Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
© 2020 International Society on Thrombosis and Haemostasis..
Clarity and guidance is required with regard to the use of direct oral anticoagulants in antiphospholipid syndrome (APS) patients, within the confines of the recent European Medicines Agency recommendations, discrepant recommendations in other international guidelines and the limited evidence base. To address this, the Lupus Anticoagulant/Antiphospholipid Antibodies Scientific and Standardization Committee (SSC) chair and co-chairs together with SSC Control of Anticoagulation members propose guidance for healthcare professionals to help them manage APS patients. Uncertainty in this field will be addressed. This guidance will also serve as a call and focus for research.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Journal of thrombosis and haemostasis : JTH - 18(2020), 9 vom: 05. Sept., Seite 2126-2137 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zuily, Stéphane [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 19.05.2021 Date Revised 29.08.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1111/jth.14935 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314542485 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314542485 | ||
| 003 | DE-627 | ||
| 005 | 20231225152943.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jth.14935 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1048.xml |
| 035 | |a (DE-627)NLM314542485 | ||
| 035 | |a (NLM)32881337 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zuily, Stéphane |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome |b Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.05.2021 | ||
| 500 | |a Date Revised 29.08.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 International Society on Thrombosis and Haemostasis. | ||
| 520 | |a Clarity and guidance is required with regard to the use of direct oral anticoagulants in antiphospholipid syndrome (APS) patients, within the confines of the recent European Medicines Agency recommendations, discrepant recommendations in other international guidelines and the limited evidence base. To address this, the Lupus Anticoagulant/Antiphospholipid Antibodies Scientific and Standardization Committee (SSC) chair and co-chairs together with SSC Control of Anticoagulation members propose guidance for healthcare professionals to help them manage APS patients. Uncertainty in this field will be addressed. This guidance will also serve as a call and focus for research | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a antiphospholipid antibodies | |
| 650 | 4 | |a antiphospholipid syndrome | |
| 650 | 4 | |a arterial thrombosis | |
| 650 | 4 | |a direct oral anticoagulants | |
| 650 | 4 | |a triple positivity | |
| 650 | 4 | |a venous thromboembolism | |
| 650 | 4 | |a vitamin K antagonists | |
| 650 | 7 | |a Anticoagulants |2 NLM | |
| 650 | 7 | |a Lupus Coagulation Inhibitor |2 NLM | |
| 700 | 1 | |a Cohen, Hannah |e verfasserin |4 aut | |
| 700 | 1 | |a Isenberg, David |e verfasserin |4 aut | |
| 700 | 1 | |a Woller, Scott C |e verfasserin |4 aut | |
| 700 | 1 | |a Crowther, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Dufrost, Virginie |e verfasserin |4 aut | |
| 700 | 1 | |a Wahl, Denis |e verfasserin |4 aut | |
| 700 | 1 | |a Doré, Caroline J |e verfasserin |4 aut | |
| 700 | 1 | |a Cuker, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Carrier, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Pengo, Vittorio |e verfasserin |4 aut | |
| 700 | 1 | |a Devreese, Katrien M J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of thrombosis and haemostasis : JTH |d 2003 |g 18(2020), 9 vom: 05. Sept., Seite 2126-2137 |w (DE-627)NLM126285683 |x 1538-7836 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2020 |g number:9 |g day:05 |g month:09 |g pages:2126-2137 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jth.14935 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2020 |e 9 |b 05 |c 09 |h 2126-2137 | ||